The expression of TCL1A is deregulated in lymphocytic leukemia (B-CLL) and most lymphomas, which involve several signaling pathways, such as the phosphatidylinositol 3 kinase (PI3K) and nuclear factor-kB (NF-kB) pathways (33). Here, TCL1A is linked to lymphoid leukemia.